Synthetic health data is artificially generated patient data that preserves the statistical properties of real clinical records — the distributions, correlations, and structures analysts care about — without containing any actual patient's information. A synthetic dataset looks and behaves like real clinical data: it has patients, diagnoses, medications, visits, and lab values in realistic proportions. But no row corresponds to a real person, because every record was generated by a model rather than collected from a human being.
That distinction — generated, not collected — is why synthetic data has become the most important idea in health-data privacy. Real patient data is legally radioactive: it can rarely leave the institution that holds it, and every copy multiplies breach risk. Synthetic data, done properly, carries the statistical value across the boundary while the real records stay where they are.
How is synthetic health data generated?
A generative model is trained on (or fitted to statistics of) real clinical data — electronic health records, insurance claims, registries — and learns its statistical structure: how age relates to diagnoses, how diagnoses co-occur, how utilization is distributed. The model then generates entirely new records that follow those learned patterns. Inputs commonly arrive in healthcare-native formats such as HL7 FHIR R4 or the OMOP Common Data Model, and outputs are produced in the same schemas so downstream tools work unchanged.
The critical caveat: generation alone is not a privacy guarantee. A generative model can memorize unusual records and reproduce something close to them. This is why the serious end of the field pairs synthesis with differential privacy — a mathematical ceiling on how much any single patient can influence the output. Without a formal guarantee, "synthetic" is a description of how the data was made, not of how private it is.
What synthetic data is not
- It is not masked or de-identified data. De-identification takes real records and removes or blurs identifiers; the records are still real people's data, and re-identification research keeps showing how recoverable they are. Synthetic records were never real to begin with. (Full comparison: Synthetic Data vs. De-Identification.)
- It is not "fake data" in the QA sense. Faker-style generators produce random plausible-looking values with no statistical relationship to any real population. Synthetic health data is fitted to a real cohort and is statistically faithful to it.
- It is not automatically anonymous in law. Regulators, including the EDPB in its 2026 draft anonymisation guidelines, treat synthetic data as anonymous only where identification of individuals is effectively precluded — which depends on how the synthesis was done. (Details: Is Synthetic Health Data Anonymous Under GDPR?)
What is synthetic health data good for?
Honesty about fit matters more in this field than in most, because the failure mode — trusting a synthetic dataset for a task it cannot support — happens silently. Based on the head-to-head literature comparing analyses on real versus synthetic cohorts:
| Use case | Suitability |
|---|---|
| Software testing, development and QA environments, demo data | Excellent — realistic, linkable, zero PHI in lower environments |
| Clinical trial feasibility and cohort sizing | Excellent — concordance with real-data estimates is consistently high |
| Machine-learning pre-training and AI benchmarking | Good — fine-tune on real data where possible |
| Population epidemiology | Moderate — hypothesis generation, not confirmation |
| Pharmacovigilance / safety-signal detection | Poor — rare signals live in distribution tails that privacy protection deliberately smooths |
| Rare-disease cohort analysis | Unsuitable — small cohorts and strong privacy are mathematically in tension |
| Regulatory submissions as primary evidence | Restricted — secondary/supporting evidence only |
A vendor who claims synthetic data is good for everything is telling you something about the vendor. At Synthetix Health we print contraindications on every dataset certificate for exactly this reason.
What makes a synthetic dataset trustworthy?
Three properties, each of which should be evidenced rather than asserted:
- A formal privacy guarantee. ε-differential privacy provides a provable bound on what the output reveals about any individual — one that holds against any attacker with any auxiliary data. The parameters (ε, δ) should be stated on the dataset, not hidden.
- Measured fidelity. Distribution comparisons, correlation preservation, and — for relational data like claims — referential integrity checks (does every claim resolve to a patient and a visit?), reported against the source.
- Provenance and auditability. A record of how the dataset was produced: source characteristics, parameters, privacy budget consumed, and a tamper-evident audit trail a compliance team can file.
Why synthetic health data matters now
Two forces converged. First, healthcare AI needs vastly more training and testing data than privacy law lets institutions share — and demand for realistic clinical data is growing faster than any consent process can. Second, the legal ground under the traditional alternative — de-identification — is eroding: European regulators now name identification-risk tests that policy-based masking struggles to meet, while recognising formally private methods. India's DPDP Act regime points the same direction for cross-border health data. The combination makes provably private synthesis the natural successor: the value of the data moves; the risk does not.
Frequently asked questions
Does synthetic health data contain real patient information?
No — every record is generated by a model rather than taken from a person. But the model was trained on real data, so without a formal privacy guarantee such as differential privacy, a model can memorize and partially reproduce unusual real records. Trustworthy synthetic data states its privacy guarantee explicitly.
Is synthetic health data legal to share?
Generally yes, when generated with a demonstrable privacy guarantee: data that cannot be linked to identifiable individuals falls outside HIPAA's definition of PHI and, where identification is effectively precluded, outside the GDPR's definition of personal data. The legal analysis depends on how the data was generated, which is why certification and documented parameters matter.
Can synthetic data be re-identified?
Records generated under ε-differential privacy carry a mathematical bound on what any output can reveal about any individual in the source data — a guarantee that holds regardless of attacker resources or auxiliary datasets. Synthetic data generated without such a guarantee has no such protection, and memorization-based leakage is a documented risk.
What's the difference between synthetic data and anonymized data?
Anonymized (de-identified) data is real patient data with identifiers removed or generalized — the records still belong to real people. Synthetic data consists of new, artificial records fitted to the statistics of the real cohort. De-identification subtracts information and hopes enough was removed; formally private synthesis provides a provable ceiling on disclosure.
What formats does synthetic health data come in?
The same formats as real clinical data: HL7 FHIR R4 resources, OMOP Common Data Model tables, flat CSV/Parquet extracts, or claims-shaped relational tables — so existing analytics pipelines, ETL, and tools run without modification.
- EDPB Draft Guidelines 02/2026 on Anonymisation (July 2026) — public consultation open to 30 Oct 2026
- CMS DE-SynPUF — synthetic Medicare claims public use files
- HHS guidance on HIPAA de-identification (Safe Harbor and Expert Determination)
- Synthetix Health published patent application 202641026065 · PCT/IN2026/051623
Continue reading in Research:
Working with clinical data that can't move?
Synthetix Health builds certified synthetic healthcare data infrastructure — ε-differential-privacy synthesis with a certificate and audit trail attached to every dataset.
Talk to us